Biohaven Pharmaceutical Holding Company Ltd (NYSE:BHVN)
| 145.38 Delayed Data As of Jul 01 |  -0.33 / -0.23%Today’s Change | 79.01 Today|||52-Week Range 151.51 | +5.49% Year-to-Date |
Latest BHVN News | Press Releases
| Arvinas, Inc. (ARVN) Stock Jumps 8%: Will It Continue to Soar? Jun 27 / Zacks.com - Paid Partner Content | AbbVie (ABBV) Files Qulipta sNDA for Chronic Migraine Prevention Jun 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 145.71 |
| Today’s open | 145.44 |
| Day’s range | 145.10 - 145.83 |
| Volume | 880,622 |
| Average volume (3 months) | 1,406,583 |
| Market cap | $10.3B |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -0.26% |
| Earnings growth (this year) | +13.63% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +626.91% |
| P/E ratio | NM |
| Price/Sales | 19.27 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| JAZZJazz Pharmaceuticals... | +2.53 | +1.62% |
| UTHRUnited Therapeutics ... | +2.40 | +1.02% |
| RDYDr Reddy's Laborator... | +0.42 | +0.76% |
| RGENRepligen Corp | +4.29 | +2.64% |
Data as of 4:00pm ET, 07/01/2022
Financials
| Next reporting date | August 8, 2022 |
| EPS forecast (this quarter) | -$2.58 |
| Annual revenue (last year) | $462.5M |
| Annual profit (last year) | -$846.6M |
| Net profit margin | -183.04% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
